Targeted resequencing articles within Nature Communications

Featured

  • Article
    | Open Access

    The genomic profiling of tumours has not been widely adopted in the clinic due to technical and practical hurdles. Here, the authors develop PGDx elio tissue complete, a scalable, standardised and FDA-cleared test comprising a targeted gene panel and automated machine-learning analysis, which detects clinically relevant sequence biomarkers in cancer samples.

    • Laurel A. Keefer
    • , James R. White
    •  & Mark Sausen
  • Article
    | Open Access

    High-throughput sequencing is used to identify somatic variants in cancer patients. Here, the authors perform panel-based profiling of 5095 clinical samples and demonstrate that many clinically-actionable variants have low variant allele fractions, requiring assays with high detection sensitivity.

    • Hyun-Tae Shin
    • , Yoon-La Choi
    •  & Woong-Yang Park
  • Article
    | Open Access

    Detection ofde novo, low frequency mutations is important for characterising heterogeneous cell populations, such as those found in cancer cell populations. Here the authors present o2n-seq, an ultrasensitive method with highly efficient data usage for detection of rare mutations.

    • Kaile Wang
    • , Shujuan Lai
    •  & Jue Ruan